What is he best known for?
The fields of study he is best known for:
Daniel G. Tenen focuses on Molecular biology, Transcription factor, Cancer research, Myeloid and Cellular differentiation.
His Molecular biology research includes elements of RUNX1 Translocation Partner 1 Protein, Fusion gene, Biochemistry, Messenger RNA and Transcription.
His studies deal with areas such as Promoter and Macrophage colony-stimulating factor as well as Transcription factor.
His study in Cancer research focuses on Myeloid leukemia in particular.
His Myeloid study integrates concerns from other disciplines, such as Cancer, Haematopoiesis, Mutation, Integrin alpha M and CD34.
In his study, Bone marrow, Basophil and Gene expression is strongly linked to Progenitor cell, which falls under the umbrella field of Cellular differentiation.
His most cited work include:
- EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib (3135 citations)
- Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice (824 citations)
- Dominant-negative mutations of CEBPA , encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia (775 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Cancer research, Molecular biology, Transcription factor, Haematopoiesis and Myeloid.
His Cancer research research is multidisciplinary, relying on both Carcinogenesis, Cancer and Leukemia, Immunology.
His Molecular biology research is multidisciplinary, incorporating elements of Promoter, Regulation of gene expression, Gene expression, Gene and Ccaat-enhancer-binding proteins.
The various areas that Daniel G. Tenen examines in his Transcription factor study include Chromatin and Transcription.
His Haematopoiesis research is multidisciplinary, incorporating perspectives in Progenitor cell, CD34 and Bone marrow.
The concepts of his Myeloid study are interwoven with issues in Mutation, CEBPA, Myelopoiesis and Cellular differentiation.
He most often published in these fields:
- Cancer research (51.88%)
- Molecular biology (41.09%)
- Transcription factor (44.38%)
What were the highlights of his more recent work (between 2018-2021)?
- Cell biology (36.88%)
- Cancer research (51.88%)
- Transcription factor (44.38%)
In recent papers he was focusing on the following fields of study:
His main research concerns Cell biology, Cancer research, Transcription factor, Haematopoiesis and Cancer.
He has researched Cell biology in several fields, including RNA, Chromatin, Enhancer, Gene and Transcription.
His studies in Cancer research integrate themes in fields like Carcinogenesis, Oncogene, Downregulation and upregulation, SALL4 and CD34.
In his study, Long non-coding RNA, RUNX1 and Core binding factor is inextricably linked to Myeloid leukemia, which falls within the broad field of Transcription factor.
He has included themes like Progenitor cell and Chromatin immunoprecipitation in his Haematopoiesis study.
The study incorporates disciplines such as Lung cancer and Outbreak in addition to Cancer.
Between 2018 and 2021, his most popular works were:
- Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak. (449 citations)
- Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak. (449 citations)
- Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species. (263 citations)
In his most recent research, the most cited papers focused on:
Daniel G. Tenen mainly focuses on Cancer research, Cell biology, Cancer, Lung cancer and Transcription factor.
His Cancer research study incorporates themes from Lysosome, CD34, Genetically modified mouse, Kinase and Endosome.
The Cell biology study combines topics in areas such as Cell, Embryonic stem cell and Cellular differentiation.
His work carried out in the field of Cancer brings together such families of science as RNA, Gene expression and Outbreak, Virology.
His Transcription factor study combines topics from a wide range of disciplines, such as Non-coding RNA and Regulation of gene expression.
He combines subjects such as Carcinogenesis and CEBPA with his study of Haematopoiesis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
